Department of Biomedical Engineering, University of Minnesota, 7-105 Hasselmo Hall, 312 Church St. SE, Minneapolis, MN 55455, USA.
Macromol Biosci. 2010 Nov 10;10(11):1338-44. doi: 10.1002/mabi.201000121.
It is advantageous to use biomaterials in tissue engineering that stimulate extracellular matrix (ECM) production by the cellular component. Connective tissue growth factor (CTGF) stimulates type I collagen (COL1A1) transcription, but is functionally limited as a free molecule. Using a matrix-binding domain (MBD) from microfibril-associated glycoprotein-1, the fusion protein MBD-CTGF was targeted to the ECM and tested for COL1A1 transcriptional activation. MBD-CTGF produced by the ECM-synthesizing fibroblasts, or provided exogenously, localized to the elastic fiber ECM. MBD-CTGF, but not CTGF alone, led to a two-fold enhancement of COL1A1 expression. This study introduces a targeting technology that can be used to elevate collagen transcription in engineered tissues and thereby improve tissue mechanics.
在组织工程中使用生物材料是有利的,这些生物材料可以刺激细胞成分产生细胞外基质 (ECM)。结缔组织生长因子 (CTGF) 可刺激 I 型胶原蛋白 (COL1A1) 的转录,但作为游离分子,其功能受到限制。利用微纤维相关糖蛋白 1 的基质结合结构域 (MBD),将融合蛋白 MBD-CTGF 靶向 ECM,并测试其对 COL1A1 转录的激活作用。由合成细胞外基质的成纤维细胞产生的或外源性提供的 MBD-CTGF 定位于弹性纤维 ECM。MBD-CTGF 而非单独的 CTGF 可使 COL1A1 表达增加两倍。本研究介绍了一种靶向技术,可用于提高工程组织中的胶原蛋白转录水平,从而改善组织力学性能。